🔎 Trials Near Me

Dachaigh › Ailse Endometrial › New York

Sgrùdaidhean clionaigeach Ailse Endometrial ann an New York

Tha 69 sgrùdaidhean airson Ailse Endometrial a’ lorg phàirtichean aig làraichean ann an New York.

Bailtean ann an New York

Teacsa sgrùdaidh oifigeil (Beurla)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Roswell Park Cancer Institute, Buffalo
  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • agus 8 a bharrachd
A’ fastadhÌre 2
Gach aois · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering, New York
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • START New York Long Island LLC, Lake Success
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06270706

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • Northwell Health Imbert Cancer Center, Bay Shore
  • Memorial Sloan Kettering Commack, Commack
  • Northwell Health Physician Partners at Flushing, Flushing
  • agus 20 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 2 Dàmh 2026 · NCT07198074

A Phase 1 Study of the Safety and Tolerability of CTX-10726

  • START New York, Lake Success
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07419841

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Roswell Park Cancer Institute IDS, Buffalo
  • Memorial Sloan Kettering Hospital, New York
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06172478

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • The Woman's Health Pavilion, Howard Beach
  • The Woman's Health Pavilion, Westbury
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT05051722

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • University of Rochester, Rochester
  • State University of New York Upstate Medical University, Syracuse
  • Wilmot Cancer Institute at Webster, Webster
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 28 Sult 2026 · NCT05112601

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, Mineola
  • Avenzo Therapeutics Recruiting Site, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05867251

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  • Research Site, New York
  • Research Site, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06218914

ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • agus 1 a bharrachd
A’ fastadh
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 25 Sult 2026 · NCT07270666

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 25 Sult 2026 · NCT03564340

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 24 Sult 2026 · NCT04590326

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  • Roswell Park Cancer Institute, Buffalo
  • Mount Sinai Chelsea, New York
  • Mount Sinai Hospital, New York
  • agus 4 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 24 Sult 2026 · NCT05640999

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, Commack
A’ fastadhÌre 2
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Columbia University, New York
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • New York University (NYU) Langone Medical Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07114601

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

  • START New York-Long Island, Lake Success
  • Memorial Sloan Kettering Cancer Center (MSKCC), New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07262619

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Memorial Sloan Kettering Cancer Center Head Neck Services, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT05983432

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

  • Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 21 Sult 2026 · NCT06925724

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 6055), Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 6004), New York
  • Memorial Sloan Kettering Cancer Center ( Site 6053), New York
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 17 Sult 2026 · NCT06952504

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

  • NYU Langone Hospital - Long Island, Mineola
  • NYU Langone Health, New York
  • SUNY Upstate Medical University, Syracuse
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 17 Sult 2026 · NCT06340568

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

  • Research Site, Commack
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT05123482

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06293898

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  • NYU Laura and Isaac Perlmutter Cancer Center - 34th Street, New York
  • Perlmutter CC NYU Langone LI, New York
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 9 Sult 2026 · NCT07166094

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • NYU Langone Health - Long Island, Mineola
  • New York University (NYU) Clinical Cancer Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06400472

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06515613

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT07186842

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

  • Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT07227168

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  • Icahn School of Medicine at Mount Sinai, New York
  • Montefiore Einstein Comprehensive Cancer Center, The Bronx
A’ fastadhÌre 1
Aoisean 15 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • Roswell Park Comprehensive Cancer Center, Buffalo
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT06774963

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

  • Laura & Isaac Perlmutter Cancer Center, New York
  • Memorial Sloan-Kettering Cancer Center, New York
  • Mount Sinai Health System, New York
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 21 Lùna 2026 · NCT05548296

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

  • Start - Ny, Long Island City
  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07470853

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT05919264

A Study of PHST001 in Advanced Solid Tumors

  • START Center for Cancer Research - Long Island New York, Lake Success
  • Mount Sinai, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT06840886

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START-New York Long Island, Lake Success
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT06242470

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

  • Memorial Sloan Kettering Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All protocol activities), Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • agus 1 a bharrachd
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 7 Lùna 2026 · NCT04291612

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

  • Roswell Park Comprehensive Care Center, Buffalo
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT07444814

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.